And it follows RE/MAX's announcement in August last year that it would standardize on the DocuSign eSignature platform and Transaction Rooms for Real Estate solution for its broker and agent affiliates. is the owner of DOCUSIGN® and all of its other marks, All other marks appearing herein are the property of their respective owners.The news comes as part of an ongoing initiative that represents an unprecedented level of integration between DocuSign and the RE/MAX tools used most by brokers and agents. Every day more than 50,000 new users join The DocuSign Global Trust Network to increase speed to results, reduce costs, enhance security and compliance, and delight clients with a secure digital experience. DocuSign's DTM platform supports legally compliant signature processes tailored to meet requirements globally with localization in 43 languages. More than 50 million people in 188 countries turn to DocuSign to manage their most important transactions-digitally. DocuSign helps more than 100,000 companies across nearly every industry and department make their digital transformation by putting an end to the paper chase. Washington Convention Center in Washington, D.C., June 14-18, or visit Contact:ĭocuSign® is The Global Standard for Digital Transaction Management®. Organizations interested in learning more about DocuSign may visit DocuSign Booth #744 at the DIA 2015 51 st Annual Meeting at the Walter E. (KCI), McKesson, Medtronic, TEVA, ThermoFisher Scientific, Varian Medical Systems and others. USDM Life Sciences: In the past year, numerous customers have validated compliance with 21 CFR Part 11 by adopting USDM's Cloud Assurance Offering, which allows life science organizations to manage GxP regulated business processes (Read more at)Ĭustomers who have standardized on DocuSign for DTM include Allergan, Amplifon ( USA), Inc., Astellas, AstraZeneca, Bayer, Boston Scientific, ePharmaSolutions, Kinetics Concepts, Inc.Exostar: As part of DocuSign's integration into Exostar's Life Sciences Industry Hub, life science organizations can improve clinical trial recruitment and simplify global collaboration (Read more at: ).SAFE-BioPharma: DocuSign is the first vendor of its kind to be certified as a SAFE-enabled application, extending opportunities for ecosystem collaboration in industry portals and regulatory filings (Read more at: ). (ARX) further enhances its platform capabilities and compliance offerings for biopharmaceutical companies. ARX: DocuSign's recent acquisition of Algorithmic Research, Ltd.AstraZeneca Global Chief Information Officer David Smoley recently discussed the business transformation he's led at the global biopharmaceutical company to drive a $150M reduction in IT costs for FY 2014: "We simplified and improved existing business processes by implementing multiple new cloud solutions globally including Workday for HR, Office365 to supply email, calendar and file sharing ServiceNow, Salesforce for CRM, Box for storage and DocuSign for workflow and electronic signature."ĭocuSign offers Bank-Grade security and Carrier-Grade availability to empower biopharma firms of all sizes to quickly, easily and securely send, sign and manage transactions and workflows 100% digitally in the cloud – from electronic lab records to eClinical portals, monitoring reports, Key Opinion Leader (KOL) agreements, sales contracts and more.Īs The Global Standard for Digital Transaction Management® with more than 100,000 customers and more than 50 million users in 188 countries, DocuSign offers a robust partner ecosystem and flexible APIs that allow biopharma companies to integrate DocuSign DTM with their existing technology investments.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |